CION Ameerpet
For some women pregnancy after ovarian cancer is entirely possible, and for others it is not — and no one can tell you which without knowing what your surgery removed. The answer turns on three things: whether an ovary was left, whether the uterus was left, and what the treatment after surgery did to the eggs you still had.
The answer is not the same for two women who both had ovarian cancer. It is decided by what the surgery removed, what treatment followed it, and how old you were when that treatment was given.
Anyone who answers this question without asking what was taken out is guessing. Pregnancy after ovarian cancer comes down to three practical questions, in this order: is there at least one ovary left, is the uterus still there, and did enough ovarian function survive the treatment that followed surgery.
If you had one ovary and its tube removed for an early-stage, borderline or germ cell tumour, and the other ovary and the uterus were left in place, natural conception is often possible and many women go on to have children. If staging surgery removed both ovaries and the uterus — which is the right operation for most advanced epithelial disease — then carrying your own pregnancy is not possible, and the useful conversation is about donor eggs, surrogacy where Indian law allows it, or other ways of building a family.
Between those two ends sits the group most women are actually in: an ovary and a uterus preserved, followed by chemotherapy. Platinum-based chemotherapy reduces the number of eggs held in reserve. Periods often return, particularly in women under 35, but a returned period tells you the ovary is working now, not that it will still be working in five years. That is why conceiving after ovarian cancer is usually a question of timing as much as biology.
A single remaining ovary tends to ovulate in most cycles rather than every other one. Natural conception with one ovary and one tube is common, and the number that matters more is how much reserve that ovary still holds.
Nothing restores a uterus that was removed during staging surgery. If ovarian tissue remains, eggs can still be collected and fertilised, and surrogacy becomes the route to a genetic child where you are eligible under Indian law.
Platinum-based chemotherapy shortens the reproductive window rather than always closing it. Menopause tends to arrive earlier than it otherwise would, so waiting indefinitely costs something real.
Fertility-sparing surgery — removing the affected ovary and tube while leaving the other ovary and the uterus in place — is an accepted option for carefully selected women with early-stage, borderline and germ cell tumours, and in those selected women it is not considered to worsen cancer outcomes. In a Gynecologic Oncology Group study of long-term survivors of malignant ovarian germ cell tumours treated with fertility-sparing surgery and platinum-based chemotherapy, most survivors continued to have normal menstrual periods after treatment, and a substantial number went on to have children. The point is not that this applies to everyone — it applies to the women whose stage and tumour type allowed the operation in the first place. Source: Gershenson DM et al., Journal of Clinical Oncology (2007); NCCN Ovarian Cancer guidelines.
Find the rows that describe what you had. Most women have two or three of them, and the most restrictive row is the one that sets the answer.
| What you had | What it does to fertility | What that usually means |
|---|---|---|
| Fertility-sparing surgery — one ovary and tube removed | Leaves the second ovary and the uterus in place, so ovulation and natural conception continue. | Often close to normal fertility where no chemotherapy followed. More on fertility-sparing surgery and who it suits. |
| Both ovaries removed | Ends the egg supply and causes immediate surgical menopause, whatever your age. | Natural pregnancy is not possible. Frozen eggs or embryos can still be used; otherwise donor eggs are the route. |
| Uterus removed as part of staging surgery | Removes the organ that carries a pregnancy. Ovarian tissue may or may not remain. | You cannot carry a pregnancy yourself. Where eggs remain or were frozen, surrogacy is the route to a genetic child if you are eligible under Indian law. |
| Platinum-based chemotherapy | Reduces the number of eggs held in reserve. Periods may stop during treatment and return afterwards, or not return at all. | Return of periods is common under 35 and less so over 40. Treat a returned period as a working ovary now, not as a full tank. |
| PARP-inhibitor-class or anti-angiogenic maintenance therapy | Not compatible with pregnancy. Reliable contraception is required during treatment and for a defined period after it. | Trying to conceive is planned for after maintenance finishes, with your oncologist setting the interval. See how ovarian cancer treatment is sequenced. |
| Eggs or embryos frozen before treatment | Stores eggs or embryos from when your reserve was at its highest, before any chemotherapy. | Gives you an option that does not depend on what treatment leaves behind. More on egg and embryo freezing before treatment. |
*This table describes patterns, not your case. Exactly which rows apply to you is written in your operation notes and your chemotherapy record — bring both to the consultation, because they answer more in five minutes than any general guide can.
Ovarian cancer is not one disease, and fertility after it is not one conversation. These are the situations women arrive with most often.
This is the most straightforward position to be in. The remaining ovary continues to ovulate, the uterus is untouched, and there is no chemotherapy effect on your reserve. Women in this group frequently conceive naturally, often without any fertility treatment at all.
What still needs attention is timing and surveillance. You will be on follow-up with examination, ultrasound and, where relevant, CA-125, and your oncologist will want you settled in remission before you start trying. Ask specifically whether your histology was borderline or invasive, because that single word changes how long the wait usually is.
Here the anatomy is intact but the reserve has taken a hit. Whether periods return, and how quickly, depends heavily on your age at the time of treatment — under 35 the ovary usually recovers some function, over 40 it often does not. Recovery is not instant, and anti-Mullerian hormone measured within a few months of finishing chemotherapy tends to read lower than it will a year later.
The practical advice is to have your reserve assessed once, roughly six to twelve months after treatment ends, and then again if you are not yet ready to try. That gives you a trend rather than a snapshot, and a trend is what tells you whether time is on your side.
Borderline tumours behave quite differently from invasive ovarian cancer. They are commonly diagnosed in younger women, they are often confined to one ovary, and conservative surgery that preserves the other ovary and the uterus is standard practice rather than an exception.
Fertility outcomes in this group are generally good, and the wait before trying to conceive is usually shorter than for invasive disease. There is a genuine trade-off to discuss: leaving ovarian tissue behind carries a higher chance of the tumour recurring in that tissue, though such recurrences are usually treatable and are not the same thing as the disease spreading. Ask your team to spell out that trade-off for your specific pathology.
Malignant ovarian germ cell tumours occur mainly in adolescents and young women, they respond well to platinum-based chemotherapy, and the standard operation removes only the affected ovary and tube. This is the group with the most encouraging published experience of having a baby after ovarian cancer.
Most survivors resume normal periods after treatment, and pregnancies after treatment are well documented. That does not make the reserve untouched, so it is still worth measuring it rather than assuming. If you were treated as a teenager, an assessment in your late twenties is a reasonable step even if you are not planning a pregnancy yet.
This is the hardest version of the conversation, and it deserves to be said plainly rather than softened. Without ovaries there are no eggs of your own unless some were frozen beforehand. Without a uterus you cannot carry a pregnancy, whatever the ovaries are doing. No treatment reverses either.
What remains is real, though it is not what you came looking for. Donor eggs, surrogacy where you are eligible under India's surrogacy regulations, and adoption are all routes to a family, and a reproductive medicine unit will tell you where you stand legally as well as medically. Separately, surgical menopause in a young woman needs managing in its own right — bone health, cardiovascular risk and symptom control — and that discussion should not be postponed while the fertility question is being worked through.
Many women do not, because treatment started quickly or because nobody raised it. Looking back at that is understandable and rarely useful. What is useful is finding out what is there now: an anti-Mullerian hormone level, an antral follicle count and a look at the remaining ovary tell you more than any amount of reconstruction of what should have happened.
If reserve is reduced but present, freezing eggs or embryos now — after treatment, once you are in remission and off maintenance therapy — is still an option worth asking about, because reserve only falls further with time. Where nothing usable remains, the conversation moves to donor eggs, and it is better to have that conversation at 33 than at 39. Read how egg and embryo freezing works for what the process involves.
A 45-minute consultation, your operation notes and your chemotherapy record read together, and a plain answer about what is and is not possible. Where fertility treatment is the next step, we coordinate it with a reproductive medicine unit rather than leaving you to arrange it alone.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. If the answer is that pregnancy is not possible, we will tell you plainly rather than let you spend two more years finding out.
This is a joint decision between you, your oncologist and a fertility specialist. Taken in order, the steps stop you either rushing into a pregnancy too early or losing years to a wait nobody actually asked you to keep.
Most teams ask you to wait until the period of highest recurrence risk has passed. For invasive epithelial ovarian cancer, recurrence is most likely in the first two to three years, so that is the interval usually discussed; for borderline and germ cell tumours the wait is often shorter. There is no universal rule, and your interval should be set by your own oncologist against your stage, histology and how you responded — not by a number you read anywhere, including here.
PARP-inhibitor-class and anti-angiogenic maintenance treatments are not compatible with pregnancy, and a defined interval is required after the last dose before trying. Ask your oncologist for that interval in writing at the start, because it often determines the whole timeline. Reliable contraception during this phase is part of the plan rather than an afterthought.
An anti-Mullerian hormone level, an antral follicle count on transvaginal ultrasound, and early-cycle FSH give a practical picture of the remaining ovary. Taken six to twelve months after chemotherapy rather than immediately afterwards, these results are more representative — the ovary recovers some function in that window in younger women. One set of numbers is a snapshot; two sets a year apart tell you the direction of travel.
These two decisions cannot be made separately. The oncologist knows whether ovarian stimulation is reasonable for your tumour type and how long you should wait; the fertility unit knows what your reserve can realistically deliver. CION coordinates that referral and shares your records with the reproductive medicine unit, so you are not carrying files between clinics and repeating your story.
With one ovary, a uterus and reasonable reserve, the first route is usually to try naturally for a defined period before escalating. Where reserve is low, IVF may be recommended sooner. Where eggs or embryos were frozen before treatment, those are used at a fertility unit. Where the ovaries or uterus are gone, donor eggs and surrogacy come into the discussion, both of which are regulated under Indian law and handled by licensed fertility units.
A pregnancy after ovarian cancer is managed jointly with an obstetrician who knows the history. Two practical points: CA-125 rises in normal pregnancy, so it becomes unreliable for surveillance and is generally not used during those months; and imaging of the remaining ovary is done with ultrasound, or MRI without contrast where more detail is needed. Oncology follow-up resumes on the usual schedule after delivery.
Genetics belongs in this conversation too. If a BRCA or Lynch-associated variant is behind your diagnosis, each child has a one-in-two chance of inheriting that variant, and pre-implantation genetic testing is one of the options a fertility unit can discuss. Genetic counselling and BRCA and HRD testing are delivered in-house at CION, and are worth arranging before you start trying rather than during a pregnancy.
Fertility gets discussed quickly at diagnosis, when there is a great deal else to absorb, and then often not again. Coming back to it afterwards — with your operation notes, your chemotherapy record and a specialist who has time to read both — is where most of the real answers come from. Your first consultation at CION is free and runs to about 45 minutes, which is long enough to go through those records line by line rather than give you a general answer to a specific question.
CION delivers medical oncology in-house: chemotherapy and maintenance therapy across 35+ centres in Telangana and Andhra Pradesh, along with genetic counselling, BRCA and HRD testing, nutrition support and long-term survivorship follow-up. Every case that raises a question is discussed at a tumour board rather than decided by one doctor alone.
Two things we do not do ourselves, and would rather say upfront. All ovarian surgery, including fertility-sparing surgery, is delivered by specialist gynaecologic-oncology surgeons at partner centres and may be billed there — CION coordinates it and stays involved in the decision. And IVF, egg and embryo freezing, donor-egg programmes and surrogacy are carried out at reproductive medicine units, which we refer to and work alongside. What we will not do is let you leave a consultation thinking a pregnancy is likely when the records in front of us say otherwise.
Free, unhurried, and with your operation notes and chemotherapy record actually read. Bring both — they answer most of this question by themselves.
BRCA and HRD testing and counselling are delivered at CION, which matters if inheritance is part of your decision about having children.
Surgery with specialist gynaecologic-oncology partner centres; IVF and freezing with reproductive medicine units. Coordinated by us, delivered and billed there.
Follow-up and survivorship care close to where you live across Telangana and Andhra Pradesh, rather than repeat trips into one city hospital.
For many women, yes. It depends on three things: whether at least one ovary was left in place, whether the uterus was left in place, and how much ovarian reserve survived any chemotherapy. If you had fertility-sparing surgery — one ovary and tube removed for early-stage, borderline or germ cell disease — natural conception is often possible, and many women in this group have children afterwards. If both ovaries were removed, natural pregnancy is not possible, though frozen eggs or embryos or donor eggs may be. If the uterus was removed, you cannot carry a pregnancy yourself whatever the ovaries are doing. Your operation notes answer this faster than any general guide.
There is no single rule, and the honest answer is that your oncologist sets it. The reasoning is that recurrence of invasive epithelial ovarian cancer is most likely in the first two to three years after treatment, and most teams prefer you to be through that window and clearly in remission before a pregnancy begins. For borderline tumours and germ cell tumours the wait is often shorter. Two other things drive the timing: any maintenance therapy has to be finished, with a defined gap after the last dose, and your remaining ovarian reserve is falling while you wait. That second point matters — waiting is not cost-free, so ask for a specific interval rather than a vague one.
There is no good evidence that a pregnancy itself causes ovarian cancer to recur. The published experience, which comes mainly from women treated with fertility-sparing surgery for early-stage, borderline and germ cell tumours, has not shown worse cancer outcomes in those who went on to conceive. That evidence has a real limitation worth knowing: the women who become pregnant are usually those with earlier-stage disease who were already doing well, so the comparison is not a clean one. What is more certain is that pregnancy makes surveillance harder for a while — CA-125 rises normally in pregnancy and becomes unreliable — which is one reason teams prefer you to be securely in remission first.
No, and this is the single most common misunderstanding. A returning period tells you that the ovary is producing hormones and releasing eggs now. It tells you nothing about how many eggs are left. Platinum-based chemotherapy destroys part of the reserve you were born with, and that loss is permanent even when cycles resume. In practice it means two things: your fertile window is likely shorter than it would have been, and menopause tends to arrive earlier. If you want children, have your reserve measured with an anti-Mullerian hormone test and an antral follicle count rather than taking regular periods as reassurance, and do it sooner rather than later.
Only if an inherited variant is behind your diagnosis, which is true for a minority of ovarian cancers. Where a BRCA1, BRCA2 or Lynch syndrome variant is found, each child has a one-in-two chance of inheriting it — and inheriting a variant means a raised risk, not a certainty of cancer. Where no inherited variant is found, there is no specific risk to pass on. This is worth settling before you start trying rather than during a pregnancy: genetic counselling and BRCA and HRD testing are delivered in-house at CION, the result also affects your own follow-up, and if a variant is present a fertility unit can explain what pre-implantation genetic testing involves.
The first consultation is free and runs to about 45 minutes. CION delivers medical oncology for ovarian cancer in-house — chemotherapy and maintenance treatment across more than 35 centres in Telangana and Andhra Pradesh — along with genetic counselling, BRCA and HRD testing, nutrition support and survivorship follow-up. Ovarian surgery, including fertility-sparing surgery, is coordinated with specialist gynaecologic-oncology surgeons at partner centres and may be billed there, and we say so upfront. IVF, egg and embryo freezing and donor-egg programmes are carried out at reproductive medicine units we refer to and work alongside. Every case that raises a question is reviewed at a tumour board.